Journals / Haydarpaşa Numune Medical Journal / 2018 / Cilt: 58 - Sayı: 4

Awareness of Physicians Working in Kayseri of the Age Limits Related to the Use of Cough and Cold Medicines in Children

Pages
173–178
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Integrating up-to-date drug guidelines into hospital and family medicine information management systems will contribute significantly to the elimination of such shortcomings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The purpose of this study is to examine the awareness of physicians concerning the age limit regulations related to the use of cough and cold medicines (CCM) in children.
📊
Key Findings & Data:Methods: A questionnaire including 12 questions was distributed to 180 pediatricians in Kayseri.
💡
Conclusion & Impact:Integrating up-to-date drug guidelines into hospital and family medicine information management systems will contribute significantly to the elimination of such shortcomings.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: The purpose of this study is to examine the awareness of physicians concerning the age limit regulations related to the use of cough and cold medicines (CCM) in children. Methods: A questionnaire including 12 questions was distributed to 180 pediatricians in Kayseri. In the first part of the questionnaire, the questions were covering demographic characteristics. In the second part, physicians were asked about the drugs they were prescribing and that were among 30 drugs for which the age limits were changed. Results: Of the180 practitioners who participated in the study, 91 (50.56%) were aware of a new regulation on the age limits and CCM use. However, only 5 physicians involved in the study (2.77%) preferred the new arrangement where the appropriate age for all the drugs was determined. Discussion and Conclusion: Physicians’ awareness about the new regulations regarding the age limits and CCM use was at a low level. Integrating up-to-date drug guidelines into hospital and family medicine information management systems will contribute significantly to the elimination of such shortcomings.

🔖

Cite This Article

TURANOĞLU, C., KISAARSLAN, A. P., TORUN, Y. A., İNAN, B. (2018). Awareness of Physicians Working in Kayseri of the Age Limits Related to the Use of Cough and Cold Medicines in Children. Haydarpaşa Numune Medical Journal, Cilt: 58 - Sayı: 4, 173–178. https://ajindex.com/articles/195331

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Miller EK, Williams JH. The Common Cold. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF. Nelson Texbook of Pediatrics. 20th ed. Philadelphia; 2016. p. 2011–4
  2. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Medication use among children 3. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2004:CD001831. [CrossRef ] 4. Dolansky G, Rieder M. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health 2008;13:125–7. [CrossRef ] 5. T.C. Sağlık Bakanlığı İlaç ve Eczacılık Genel Müdürlüğü. Sendika, Dernek ve Firma Duyuruları, Soğuk algınlığı ve öksürük ilaçları. Available at: https://www.titck.gov.tr/PortalAdmin/Uploads/ Titck/Dynamic/%C4%B0la%C3%A7%20G%C3%BCvenl i%C4%9Fi%20%C4%B0z leme,%20De%C4%9Fer - lendirme%20%C5%9Eube%20M%C3%BCd%C3%BCrl% C3%BC%C4%9F%C3%BC%20-%20T%C3%9CFAM/ Soguk_alginligi_14f9cb4.pdf. Accessed Aug 1, 2018
  3. T.C. Sağlık Bakanlığı İlaç ve Eczacılık Genel Müdürlüğü. Sendika, Dernek ve Firma Duyuruları, Pseudoefedrin içeren müstahzarlar. Available at: https://www.titck.gov.tr/PortalAdmin/ Uploads/Titck/Dynamic/Ruhsatl%C4%B1%20 %C3%9Cr%C3%BCn l e r-2%20%C5%9Eube%20 M%C3%BCd%C3%BCrl%C3%BC%C4%9F%C3%BC/1699_ aa5d8ea.pdf. Accessed Aug 1, 2018
  4. T.C. Sağlık Bakanlığı, Türkiye İlaç ve Tıbbi Cihaz Kurumu; Sendika, Dernek ve Firma Duyuruları, 23.07.2013. Available at: https://titck.gov.tr/storage/dynamicModulesAttachment/ 0484_587b162.pdf. Accessed Jan 02, 2019
  5. US Food and Drug Administration. Briefing information: joint meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee, October 18-19, 2007. Available at: http://www.fda.gov/ ohrms/dockets/ac/07/briefing/ 2007-4323b1-00-index.htm. Accessed Oct 31, 2013
  6. Consumer Healthcare Products Association. Makers of OTC cough and cold medicines announce voluntary withdrawal of oral infant medicines. Available at: http://www.chpa-info. org/10_11_07_OralInfantMedicines.aspx. Accessed Jun 7, 2013
  7. Consumer Healthcare Product Association. Statement from CHPA on Health Canada’s Label Updates to OTC Children’s Oral Cough and Cold Medicines. Available at: www.chpa-info. org/10_07_08_pedcc.aspx. Accessed Aug 1, 2018
  8. American Academy of Pediatrics. Withdrawal of cold medicines: addressing parent concerns. Available at: http:// www.aap.org/enus/professional-resour